IGFBP1 and metabolic dysfunction-associated steatotic liver disease: Table 1 shows the coefficients (95% CI) for the associations that were significant for the stages of NAFLD in the crude analysis and remain significant after adjusting by hepatic lipid contents; these associations were confirmed for IGFBP-1, -2, and -7.